What is the current stock price of ImpediMed Limited (IPDQF)?

As of the latest market data, ImpediMed Limited (IPDQF) is trading at $0.01. The stock has seen a loss of -39.10% today.

Does ImpediMed Limited (IPDQF) pay a dividend?

Based on current data, ImpediMed Limited does not have a confirmed active dividend policy.

What is the market cap of ImpediMed Limited?

The current market capitalization of ImpediMed Limited (IPDQF) is approximately unavailable.

IPDQF

ImpediMed Limited·Healthcare

0.01

39.098%(−0.01)

Market Closed

0.02

88.272%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0152W H: $0.05

IPDQF NEWS

seekingalpha.com

4d ago

ImpediMed Limited (IPDQF) Shareholder/Analyst Call Prepared Remarks Transcript

seekingalpha.com

Jan 28

ImpediMed Limited (IPDQF) Q2 2026 Earnings Call Transcript

Company Profile

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2012-09-25

Beta

1.27

Websitewww.impedimed.com↗